🔎 Trials Near Me

Home › Type 1 Diabetes › NCT07793097

Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?

Recruiting

Feasibility of MBSR-VR to Reduce Stress Among Emerging Adults With T1D

Who can join

Ages 16 to 20 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Age 16 to 20 years, inclusive
* Diagnosed with type 1 diabetes (T1D) for at least six months
* Have elevated levels of stress reactivity as assessed by the Perceived Stress Reactivity Scale (PSRS)
* Access to an internet-enabled device on which the participant can participate in virtual study activities

Exclusion Criteria:

* Significant co-morbid mental health problems limiting the participant's ability to engage effectively in the group nature of the intervention (i.e., thought disorders like schizophrenia, severe cognitive impairment, suicidality or homicidality)
* Co-morbid physical health problems in which diabetes is secondary to another chronic medical illness (e.g., cystic fibrosis) and their medical management differs substantially from that of most youth with T1D
* Non-English fluency

About the study

The goal of this study is to learn if Mindfulness-Based Stress Reduction (MBSR) can be delivered using virtual reality (VR) technology to emerging adults (youth 16-20 years old) with type 1 diabetes and high levels of stress reactivity. If successful, MBSR-VR has the potential to reach many people who may be living in different places who might not have access to programs like MBSR. This is important because young adults with a chronic illness like diabetes and high levels of stress have been shown to have worse health than young adults with lower stress and young adults without diabetes. This study has not been designed to determine if MBSR-VR improves the health of young adults with diabetes (improves their glycemic control),their feelings of distress (this includes stress, depression, and anxiety), or their mindfulness (being more aware of their thoughts, feelings, actions, and environment) but we will look to see if people are reporting improvements in these areas.

What is being tested

Sponsor: Wayne State University · Participants: 48 · Started: Nov 3, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07793097

Locations in the U.S.

MarylandJohns Hopkins University, Baltimore
MichiganWayne State University, Detroit

Conditions

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.